(Q40592040)

21 September 2017

1 reference

title

Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin? (English)

1 reference

21 September 2017

0 references

1 reference

1 reference

M Sarter

1

1 reference

PubMed ID

7855215

21 September 2017

language of work or name

1 reference

1 May 1994

1 reference

21 September 2017

12

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

21 September 2017

114

1 reference

21 September 2017

539-550

1 reference

21 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02244983

21 September 2017

0 references

cites work

The disorder of consciousness in schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Memory performance in individuals with primary degenerative dementia: its similarity to diazepam-induced impairments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Gating and habituation of the startle reflex in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Acetylcholine released from cerebral cortex in relation to state of activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

A theory of dopamine function and its role in cognitive deficits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Human memory and the cholinergic system. A relationship to aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Memory decline in the aged: treatment with lecithin and physostigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

The New York High-Risk Project: anhedonia, attentional deviance, and psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Selective attention skills in Alzheimer's disease: performance on graded cancellation tests varying in density and complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Divided attention, as measured by dichotic speech performance, in dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Significance of the positive-negative distinction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

The mechanism of excitation by acetylcholine in the cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Cognitive slowing in Alzheimer's disease and geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Information processing and attentional functioning in the developmental course of schizophrenic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Sparing of attentional relative to mnemonic function in a subgroup of patients with dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Benzodiazepines in the treatment of schizophrenia: a review and reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Diazepam-induced amnesia: a neuropharmacological model of an "organic amnestic syndrome".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244983

Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence

21 January 2018

1 reference

12 December 2020

Cognitive effects of L-deprenyl in Alzheimer's disease.

1 reference

12 December 2020

Changes in cortical acetylcholine output induced by modulation of the nucleus basalis.

1 reference

12 December 2020

Characterizing anticholinergic abuse in community mental health

1 reference

12 December 2020

Cognitive alterations as markers of vulnerability to schizophrenia

1 reference

12 December 2020

Improved radial maze performance induced by the benzodiazepine antagonist ZK 93 426 in lesioned and alcohol-treated rats.

1 reference

12 December 2020

Coping with attentional disorders as a systemic process in schizophrenic patients

1 reference

12 December 2020

Attention and Driving Skills in Aging and Alzheimer's Disease

1 reference

12 December 2020

Benzodiazepines and vigilance performance: a review

1 reference

12 December 2020

Neurochemistry of behaviour

1 reference

12 December 2020

Anxiogenic drugs beta-CCE and FG 7142 increase extracellular dopamine levels in nucleus accumbens

1 reference

12 December 2020

Effects of oral scopolamine on human stimulus evaluation

1 reference

12 December 2020

Acetylcholine modifies neuronal acoustic rate-level functions in guinea pig auditory cortex by an action at muscarinic receptors

1 reference

12 December 2020

Neuropsychological effects of L-deprenyl in Alzheimer's type dementia.

1 reference

12 December 2020

Cholinergic 'blockade' as a model of the cognitive deficits in Alzheimer's disease

1 reference

12 December 2020

Large-scale neurocognitive networks and distributed processing for attention, language, and memory

1 reference

12 December 2020

Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry

1 reference

12 December 2020

Trihexyphenidyl abuse: therapeutic implications for negative symptoms of schizophrenia?

1 reference

12 December 2020

Muscarinic cholinergic hyperactivity in schizophrenia. Relationship to positive and negative symptoms.

1 reference

12 December 2020

Controlled and automatic information processing in senile dementia: a review

1 reference

12 December 2020

The effects of diisopropylfluorophosphonate in schizophrenia and manic depressive psychosis

1 reference

12 December 2020

Amnesic syndrome in schizophrenia.

1 reference

12 December 2020

Cholinergic hyperactivity and negative symptoms: behavioral effects of physostigmine in normal controls.

1 reference

12 December 2020

Scopolamine and the control of attention in humans.

1 reference

12 December 2020

Adverse effects of single therapeutic doses of diazepam on performance in normal geriatric subjects: relationship to plasma concentrations.

1 reference

12 December 2020

The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance.

1 reference

12 December 2020

Modelling dementia: effects of scopolamine on memory and attention

1 reference

12 December 2020

Ventral pallidal neuronal responses to dopamine receptor stimulation in the nucleus accumbens

1 reference

12 December 2020

Physostigmine, a highly potent antidote for acute experimental diazepam intoxication.

1 reference

12 December 2020

Human information-processing: some effects of methylphenidate, age, and scopolamine.

1 reference

12 December 2020

Adverse effects of anticholinergic medication on positive schizophrenic symptoms.

1 reference

12 December 2020

Long-term enhancement of evoked potentials in cat somatosensory cortex produced by co-activation of the basal forebrain and cutaneous receptors

1 reference

12 December 2020

Cholinergic enhancement of direction selectivity in the visual cortex of the cat.

1 reference

12 December 2020

Signal detection indices in schizophrenics on a visual, auditory, and bimodal Continuous Performance Test

1 reference

12 December 2020

The attention system of the human brain

1 reference

12 December 2020

Cholinergic systems in mammalian brain and spinal cord

1 reference

12 December 2020

Effects of cholinergic depletion on neuron activities in the cat visual cortex.

1 reference

12 December 2020

Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood

1 reference

12 December 2020

SOME BEHAVIORAL CHANGES IN MAN FOLLOWING ANTICHOLINESTERASE ADMINISTRATION

1 reference

12 December 2020

Characterization of dopamine release in the rat medial prefrontal cortex as assessed by in vivo microdialysis: comparison to the striatum

1 reference

12 December 2020

The positive:negative dichotomy in schizophrenia.

1 reference

12 December 2020

Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease

1 reference

12 December 2020

Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors.

1 reference

12 December 2020

Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat.

1 reference

12 December 2020

Antipsychotic medication effects on neuropsychological functions

1 reference

12 December 2020

Diazepam in high doses is effective in schizophrenia.

1 reference

12 December 2020

Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

1 reference

12 December 2020

Nucleus basalis and thalamic control of neocortical activity in the freely moving rat.

1 reference

12 December 2020

Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine.

1 reference

12 December 2020

Effects of flunitrazepam on memory and their reversal by two antagonists.

1 reference

12 December 2020

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

1 reference

12 December 2020

Elementary neuronal dysfunctions in schizophrenia

1 reference

12 December 2020

A comparison of the effects of scopolamine and diazepam on working memory.

1 reference

12 December 2020

Cholinergic modulation of the functional organization of the cat visual cortex.

1 reference

12 December 2020

A review of the neurophysiological effects of lysergic acid diethylamide (LSD) and other phychotomimetic agents

1 reference

12 December 2020

Cell excitation enhances muscarinic cholinergic responses in rat association cortex.

1 reference

12 December 2020

Hippocampal function and schizophrenia. Experimental psychological evidence

1 reference

12 December 2020

Comparison of radial maze performance of rats after ibotenate and quisqualate lesions of the forebrain cholinergic projection system: effects of pharmacological challenge and changes in training regime.

1 reference

12 December 2020

Cholinergic controversies.

1 reference

12 December 2020

INPUT DYSFUNCTION IN SCHIZOPHRENIA

1 reference

12 December 2020

Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type.

1 reference

12 December 2020

Substantia innominata: critical link in the behavioral expression of mesolimbic dopamine stimulation in the rat.

1 reference

12 December 2020

Dissociation between the effects of benzodiazepine receptor agonists on behavioral vigilance and responsitivity

1 reference

12 December 2020

Electrophysiological studies of acetylcholine and the role of the basal forebrain in the somatosensory cortex of the cat. II. Cortical neurons excited by somatic stimuli

1 reference

12 December 2020

Cholinergic modulation of sensory responses in rat primary somatic sensory cortex

1 reference

12 December 2020

Directed and divided attention in Alzheimer's disease: impairment in shifting of attention to global and local stimuli

1 reference

12 December 2020

Failure of a chlordiazepoxide to reproduce the behavioral effects of muscimol administered into the basal forebrain

1 reference

12 December 2020

Generalized cognitive slowing and severity of dementia in Alzheimer's disease: implications for the interpretation of response-time data

1 reference

12 December 2020

Benzodiazepine augmentation of neuroleptic treatment in patients with schizophrenia

1 reference

12 December 2020

Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls

1 reference

12 December 2020

Cognitive abnormalities and schizophrenic symptoms.

1 reference

12 December 2020

Interactions between the effects of basal forebrain lesions and chronic treatment with MDL 26,479 on learning and markers of cholinergic transmission

1 reference

12 December 2020

Effects of lorazepam on memory, attention and sedation in man.

1 reference

12 December 2020

Short-term memory impairments in Alzheimer-type dementia: evidence for separable impairments of articulatory rehearsal and long-term memory.

1 reference

12 December 2020

Basal forebrain and frontal cortex neuron responses during visual discrimination in the rat.

1 reference

12 December 2020

Anxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls

1 reference

12 December 2020

Effects of GABA compounds injected into the subpallidal regions of rat brain on nucleus accumbens evoked hyperactivity

1 reference

12 December 2020

Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands

1 reference

12 December 2020

Cholinergic depletion prevents expansion of topographic maps in somatosensory cortex

1 reference

12 December 2020

Dopaminergic regulation of cortical acetylcholine release.

1 reference

12 December 2020

A role for acetylcholine in conditioning-related responses of rat frontal cortex neurons: microiontophoretic evidence

1 reference

12 December 2020

Evidence for a cholinergic mechanism of "learned" changes in the responses of barrel field neurons of the awake and undrugged rat.

1 reference

12 December 2020

Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification

1 reference

12 December 2020

Toward modeling age-related changes of attentional abilities in rats: simple and choice reaction time tasks and vigilance

1 reference

12 December 2020

Visual controlled information processing resources and formal thought disorder in schizophrenia and mania.

1 reference

12 December 2020

Visuospatial attention in dementia of the Alzheimer type

1 reference

12 December 2020

Disruptive effects of muscimol infused into the basal forebrain on conditional discrimination and visual attention: differential interactions with cholinergic mechanisms.

1 reference

12 December 2020

Psychiatric sequelae of chronic exposure to organophosphorus insecticides

1 reference

12 December 2020

Measurement and interpretation of changes in memory in response to drug treatments

1 reference

12 December 2020

The basis for choice reaction time slowing in Alzheimer's disease

1 reference

12 December 2020

Ventral pallidum projections to mediodorsal nucleus of the thalamus: an anatomical and electrophysiological investigation in the rat

1 reference

12 December 2020

Crossmodal divided attention in rats: effects of chlordiazepoxide and scopolamine.

1 reference

12 December 2020

Benzodiazepines, memory and mood: a review

1 reference

12 December 2020

Attenuation of muscarinic receptor blockade-induced impairment of spatial delayed alternation performance by the triazole MDL 26,479

1 reference

12 December 2020

Cardiovascular effects of the benzodiazepine receptor partial inverse agonist FG 7142 in rats.

1 reference

12 December 2020

Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB.

1 reference

12 December 2020

Disorders of attention and perception in early schizophrenia

1 reference

12 December 2020

The distinction of positive and negative symptoms. The failure of a two-dimensional model

1 reference

12 December 2020

Cholinergic modulation of responses to single tones produces tone-specific receptive field alterations in cat auditory cortex

1 reference

12 December 2020

High dose diazepam in schizophrenia.

1 reference

12 December 2020

Microbehavioural analysis of the choice reaction time response in senile dementia.

1 reference

12 December 2020

Thalamic radiodensity and cognitive performance in mild and moderate dementia of the Alzheimer type.

1 reference

12 December 2020

No response to high-dose muscarinic agonist therapy in Alzheimer's disease

1 reference

12 December 2020

Influence of substantia innominata neuronal activity on neocortex neuronal reactions during conditioned reflex.

1 reference

12 December 2020

Cholinergic involvement in mental disorders

1 reference

12 December 2020

Human studies on the benzodiazepine receptor antagonist beta-carboline ZK 93,426: preliminary observations on psychotropic activity

1 reference

12 December 2020

Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.

1 reference

12 December 2020

Nucleus basalis stimulation facilitates thalamocortical synaptic transmission in the rat auditory cortex

1 reference

12 December 2020

Diazepam treatment of early symptoms of schizophrenic relapse.

1 reference

12 December 2020

Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments

1 reference

12 December 2020

A cancellation test: its reliability in assessing attentional deficits in Alzheimer's disease

1 reference

12 December 2020

Convergent cholinergic activities in aging and Alzheimer's disease.

1 reference

12 December 2020

Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes

1 reference

12 December 2020

Age-dependent modulation of in vivo cortical acetylcholine release by benzodiazepine receptor ligands

1 reference

12 December 2020

The use of semantic knowledge in Alzheimer's disease: evidence for impairments of attention

1 reference

12 December 2020

Evolving conceptions of memory storage, selective attention, and their mutual constraints within the human information-processing system

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02244983

1 reference

PubMed ID

7855215

Dimensions Publication ID

21 September 2017

0 references

1 reference

PubMed ID

7855215